Cytokinetics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $17,755 | $1,936 | $66,769 | $1,579 |
Gross Profit | 17,755 | -743 | 64,483 | -98,262 |
EBITDA | -180,352 | -277,177 | -107,820 | -136,130 |
EBIT | -183,031 | -279,856 | -110,105 | -138,430 |
Net Income | -183,031 | -306,178 | -134,370 | -161,376 |
Net Change In Cash | 17,755 | 1,936 | 66,769 | 1,579 |
Free Cash Flow | -148,294 | -116,859 | -132,381 | -137,281 |
Cash | 882,221 | 225,467 | 74,940 | 73,680 |
Basic Shares | 122,434 | 119,982 | 119,457 | 118,496 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $88,039 | $18,474 | $7,530 | $94,588 |
Gross Profit | 88,039 | -320,934 | -322,593 | -146,225 |
EBITDA | -775,269 | -493,483 | -456,684 | -329,400 |
EBIT | -784,955 | -503,014 | -468,576 | -337,799 |
Net Income | -784,955 | -589,526 | -526,244 | -388,955 |
Net Change In Cash | 88,039 | 18,474 | 7,530 | 94,588 |
Cost of Revenue | -45,484 | |||
Free Cash Flow | -534,816 | -399,796 | -415,749 | -310,851 |
Cash | 882,221 | 94,857 | 113,024 | 65,582 |
Basic Shares | 120,103 | 111,979 | 96,524 | 89,825 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.50 |
2025-09-30 | -$2.55 |
2025-06-30 | -$1.12 |
